Anbio Biotechnology Foreign Currency Transaction Gain (Loss), before Tax
Anbio Biotechnology (NNNN) reported Foreign Currency Transaction Gain (Loss), before Tax of $493.56 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-04-07
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|
| 2025-12-31 | $493.56K 20-F · filed 2026-04-07 |
| 2024-12-31 | $20.47K 20-F · filed 2026-04-07 |
| 2023-12-31 | $119.42K 20-F · filed 2026-04-07 |
| 2022-12-31 | -$262.22K 20-F · filed 2025-04-28 |